NCT04397809View on ClinicalTrials.gov

Utility of CD64 and TLR2 Assays to Diagnose Acute Pulmonary Exacerbations in Cystic Fibrosis

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

September 10, 2014

Primary Completion Date

May 23, 2019

Study Completion Date

August 31, 2021

Conditions
Cystic Fibrosis
Trial Locations (1)

80206

National Jewish Health, Denver

All Listed Sponsors
lead

National Jewish Health

OTHER

NCT04397809 - Utility of CD64 and TLR2 Assays to Diagnose Acute Pulmonary Exacerbations in Cystic Fibrosis | Biotech Hunter | Biotech Hunter